Isfahan University of Medical Sciences

Science Communicator Platform

Share By
The Growth of A549 Cell Line Is Inhibited by Pemetrexed Through Up-Regulation of Hsa-Mir-320A Expression Publisher

Summary: PMX chemotherapy boosts hsa-MiR-320a levels, which may predict treatment effectiveness in lung cancer. Could this MiRNA indicate future therapies? #LungCancer #MicroRNA

Ghorbani Alvanegh A ; Esmaeili Gouvarchinghaleh H ; Ganji S
Authors

Source: Advanced Biomedical Research Published:2024


Abstract

Background: Lung cancer deaths are increasing worldwide and the most common form of lung cancer treatment is chemotherapy. Pemetrexed (PMX) has been shown to be effective as a second‑line treatment for advanced patients. Drugs can alter the expression of MicroRNAs, and MicroRNAs also can either enhance or reduce the drug’s effectiveness and this is a two‑way relationship. Hsa‑MiR‑320a is known to play a crucial role in the lung cancer. This study aims to investigate the expression of hsa‑MiR‑320a in lung cancer cells after treatment with PMX. Materials and Methods: A549 cells were cultured and treated with varying concentrations of PMX. Various parameters were measured, including cell viability, reactive oxygen species (ROS) production, lactate dehydrogenase (LDH) release, apoptosis assay, caspase 3 and 7 enzyme activity, and scratch assay. Additionally, gene expression profiles of hsa‑MiR‑320a, VDAC1, STAT3, BAX, and BCL2 were evaluated. Results: PMX reduced the viability and increased apoptosis. After 48 h, ROS production was 3.366‑fold higher than in control cells and the LDH release rate was increased by 39%. PMX also up‑regulated the expression of hsa‑MiR‑320a by about 12‑fold change. Conclusion: Changes in the expression of MicroRNAs occur after chemotherapy, and these changes play a crucial role in regulating the growth of cancer cells. Identifying these MicroRNAs can be helpful in predicting the efficacy of the chemotherapy or introducing it as combination therapy. Our research has been shown that hsa‑MiR‑320a can serve as a biomarker of PMX efficacy and also has the potential to be used in combination therapy. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Antiproliferative Effect of Upregulation of Hsa-Let-7C-5P in Human Acute Erythroleukemia Cells, Cytotechnology (2018)
2. Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer, Cancer Gene Therapy (2017)
3. Investigating the Potential Role of Mir-451A As a Tumor Suppressor in Immunogenic Cell Death Induction and Dendritic Cell Maturation in Colorectal Cancer Cell Lines, Cancer Cell International (2025)
Experts (# of related papers)
View all Related Experts
Mohammadreza Sharifi (7)
Alireza Andalib (3)
The Growth of A549 Cell Line Is Inhibited by Pemetrexed Through Up-Regulation of Hsa-Mir-320A Expression
Other Related Docs
4. Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression, Biomedicine and Pharmacotherapy (2017)
5. The Upregulation of Hsa-Mir-181B-1 and Downregulation of Its Target Cyld in the Late-Stage of Tumor Progression of Breast Cancer, Indian Journal of Clinical Biochemistry (2020)
6. Effects of Pomegranate Seed Extract and Ellagic Acid on Mir-16-5P and Mir-34A-5P Expression, Cell Cycle, and Apoptosis in Mcf-7 Cells, Research in Pharmaceutical Sciences (2026)
7. Silencing of Tim-3 Expression by Mir-326 Affects Apoptosis and Proliferation of Human Hl-60 Leukemia Cell Line, UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi (2018)
8. The Role of Unfolded Protein Response-Associated Mirnas in Immunogenic Cell Death Amplification: A Literature Review and Bioinformatics Analysis, Life Sciences (2023)
9. Dysregulated Expression and Functions of Microrna-330 in Cancers: A Potential Therapeutic Target, Biomedicine and Pharmacotherapy (2022)
10. Inhibition of Microrna Mir-222 With Lna Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia, Indian Journal of Hematology and Blood Transfusion (2017)
11. The Role of Mir-16 and Mir-34A Family in the Regulation of Cancers: A Review, Heliyon (2025)
12. Microrna Dysregulation and Its Impact on Apoptosis-Related Signaling Pathways in Myelodysplastic Syndrome, Pathology Research and Practice (2024)
13. Microrna-200C Overexpression in Cancer-Associated Fibroblasts Reduces the Invasive Properties of Breast Tumour Cells, Clinical and Translational Discovery (2022)
14. Inhibition of Microrna Mir-92A Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia; [Mikrorna Mir-92A Inhibisyonu Insan Akut Promyelositik Losemide Hucre Proliferasyonunu Inhibe Eder], Turkish Journal of Hematology (2013)
15. Mir-574, Mir-499, Mir-125B, Mir-106A, and Mir-9 Potentially Target Tgfbr-1 and Tgfbr-2 Genes Involving in Inflammatory Response Pathway: Potential Novel Biomarkers for Chronic Lymphocytic Leukemia, Pathology Research and Practice (2022)
16. Mir-204-5P Mediates Perk Inhibition to Suppress Growth and Induce Apoptosis in Ovarian Cancer Through the Eif2α/Atf-4/Chop Pathway, Scientific Reports (2025)